COMPOSITION DE VACCIN COMPRENANT DES ACIDES NUCLEIQUES IMMUNOSTIMULATEURS COMPLEXES ET ANTIGENES EMBALLES AVEC DES CONJUGUES DE POLYETHYLENEGLYCOL/PEPTIDE A LIAISON DISULFURE
The present invention is directed to a composition or vaccine composition comprising a) an adjuvant component comprising or consisting of at least one immunostimulatory nucleic acid sequence, complexed with a complexing agent； b) an antigen, preferably a protein or peptide antigen and/or a nucleic acid sequence encoding said antigen； and c) a carrier molecule for combined packaging the adjuvant component and the antigen. The present invention is also directed to the first medical use of such a composition or vaccine composition and to the second medical use of such a composition or vaccine composition or components thereof for the treatment of diseases, such as infectious or cancer or tumour diseases as defined herein. The present invention furthermore discloses kits comprising such a composition or vaccine composition.
